• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

Article on "ADDIA’s algorithms"

 

 

 

 

 

We are pleased to announce that AMONETA Diagnostics has exceeded €184k in participatory fundraising with a commitment this week from SODIV, a regional fund Grand Est.

ADDIA is the first non-invasive IVD test performed on a single blood sample and will be CE and IVD certified by the end of 2019. The clinical study supported by the Alzheimer Association Europe is conducted in 13 European centers of excellence, making it the largest in vitro clinical study ever conducted in the world.

You will find all the information related to our project and can also participate in its realization by following this link: https://www.happy-capital.com/projet/amoneta-diagnostics/page

 

More details on our project:

- Projet ADDIA soutenu par la Commission européenne Horizon2020

- Étude Clinique ADDIA publiée sur Clinicaltrials.gov

- Présentation scientifique des résultats des tests ADDIA à l'AAIC, juillet 2018, Chicago

- Publication de la biobanque ADDIA sur AE WEB

 

Presse :

  • DNA : 11 Janvier 2019 : https://www.dna.fr/sante/2019/01/11/les-algorithmes-d-alzheimer (article en pièce jointe .pdf)
  • L’Alsace : 11 Janvier 2019 : https://www.lalsace.fr/haut-rhin/2019/01/11/les-algorithmes-d-alzheimer
  • L’actu.fr : 16 Janvier 2019 : https://actu.fr/societe/alzheimer-maladie-bientot-diagnostiquee-grace-une-simple-prise-sang_20873112.html

Reportage vidéo :

  • France 3 Alsace : 11 Janvier 2019 : https://www.youtube.com/watch?v=CCh85mP_9jA&feature=youtu.be

Reportage audio :

  • RTL : 16 Janvier 2019 : https://www.rtl.fr/actu/bien-etre/alzheimer-la-maladie-bientot-diagnostiquee-grace-a-une-prise-de-sang-7796243926

16.01.2019

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE